Your browser doesn't support javascript.
loading
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors.
Tsai, Hui-Jen; Shiah, Her-Shyong; Chang, Jang-Yang; Su, Wu-Chou; Chiang, Nai-Jung; Chen, Li-Tzong.
Afiliación
  • Tsai HJ; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. hjtsai@nhri.org.tw.
  • Shiah HS; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan. hjtsai@nhri.org.tw.
  • Chang JY; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. hjtsai@nhri.org.tw.
  • Su WC; Division of Hematology and Oncology, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.
  • Chiang NJ; Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.
  • Chen LT; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.
Sci Rep ; 11(1): 4834, 2021 03 01.
Article en En | MEDLINE | ID: mdl-33649501
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon / Sorafenib Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon / Sorafenib Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Taiwán